Intelligent Bio Solutions Inc. (INBS) shares jumped 187.68%, trading at $11.80, up $7.70, after the company announced a new manufacturing partnership aimed at strengthening global production capabilities and improving margins.
The stock rallied sharply following news that Intelligent Bio Solutions has entered into a strategic agreement with a manufacturing partner to expand capacity, enhance operational efficiency, and support global supply chain execution for its biologics and vaccine products.
On the day of the announcement, INBS opened near $4.10, rallied to an intraday high above $12.00, and reached a low of $4.05, compared to its previous close of $4.10. The stock trades on the Nasdaq.
Trading volume was far exceeding the stock's average daily volume, reflecting strong investor response tied to the partnership news.
Intelligent Bio Solutions' 52-week range is approximately $1.50 - $13.10, highlighting significant volatility tied to company developments and strategic news flow.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.